Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Operating Expenses (2019 - 2025)

Bioadaptives' Operating Expenses history spans 7 years, with the latest figure at $255700.0 for Q4 2025.

  • Quarterly results put Operating Expenses at $255700.0 for Q4 2025, down 24.2% from a year ago — trailing twelve months through Dec 2025 was $1.1 million (up 74.0% YoY), and the annual figure for FY2025 was $1.1 million, up 74.0%.
  • Operating Expenses for Q4 2025 was $255700.0 at Bioadaptives, down from $269540.0 in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $337339.0 in Q4 2024 to a low of $20955.0 in Q1 2023.
  • The 5-year median for Operating Expenses is $133695.5 (2022), against an average of $148787.1.
  • The sharpest move saw Operating Expenses surged 820.62% in 2021, then plummeted 88.11% in 2023.
  • Year by year, Operating Expenses stood at $178876.0 in 2021, then tumbled by 84.16% to $28332.0 in 2022, then soared by 127.6% to $64483.0 in 2023, then skyrocketed by 423.14% to $337339.0 in 2024, then decreased by 24.2% to $255700.0 in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $255700.0, $269540.0, and $280282.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.